Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : 9 meters biopharma, inc. symbols : AZN save search
Global GLP-1 Receptor Agonist Market Research Report to 2027 - Featuring Novo Nordisk, PegBio and Sanofi Among Others
Published: 2022-04-26 (Crawled : 20:00) - prnewswire.com
AZNCF | News | $136.2 -4.19% 1.7K
|
Health Technology
|
| O: 3.45%
H: 0.0%
C: -3.43%
NVO | News | $125.26 2.08% 0.18% 3.6M
|
Health Technology
|
| O: -0.91%
H: 1.47%
C: 0.53%
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M
|
Health Technology
|
| O: 1.94%
H: 0.59%
C: -0.2%
AMGN | News | $271.98 1.13% 1.12% 2.1M
|
Health Technology
|
| O: -0.33%
H: 1.2%
C: -0.1%
NMTR | $0.0722 -42.97% -67.9% 10M
|
Health Technology
|
| O: -0.22%
H: 5.12%
C: -0.7%
research report sanofi market
Worldwide Short Bowel Syndrome Industry to 2026 - Development of Short Bowel Syndrome Drugs is at a Nascent Stage Presents Opportunities
Published: 2021-09-17 (Crawled : 17:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
AZN | News | $70.12 2.29% 2.24% 4.8M
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
NMTR | $0.0722 -42.97% -67.9% 10M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
drug syndros
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.